Repare Therapeutics Raises US$68 Million Series A

Repare Therapeutics Raises US$68 Million Series A Novel cancer company founded by Versant Ventures   June 22, 2017, Montreal, Quebec and Cambridge, Mass.   Repare Therapeutics Inc. today announced a US$68 million Series A financing to advance its platform and pipeline of novel medicines that target genetically defined weaknesses of cancers. Founding investor Versant Ventures…

Read more